Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices-Reference-Cited by-同舟云学术

Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices

Published:2022-09-01 Issue:9 Volume:45 Page:1246-1253
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Sasaki Yuko¹,Tatsuoka Hirotaka¹,Tsuda Masahiro¹,Sumi Takumi²,Eguchi Yuka²,So Kanako¹,Higuchi Yuriko²,Takayama Kazuo³,Torisawa Yusuke⁴,Yamashita Fumiyoshi²

Affiliation:

1. Department of Applied Pharmaceutics and Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyoto University

2. Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University

3. Center for iPS Cell Research and Application (CiRA), Kyoto University

4. Department of Micro Engineering, Graduate School of Engineering, Kyoto University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/45/9/45_b22-00092/_pdf

Reference30 articles.

1. 1) Wu Q, Liu J, Wang X, Feng L, Wu J, Zhu X, Wen W, Gong X. Organ-on-a-chip: recent breakthroughs and future prospects. Biomed. Eng. Online, 19, 9 (2020).

2. 2) Yamaura Y, Chapron BD, Wang Z, Himmelfarb J, Thummel KE. Functional comparison of human colonic carcinoma cell lines and primary small intestinal epithelial cells for investigations of intestinal drug permeability and first-pass metabolism. Drug Metab. Dispos., 44, 329–335 (2016).

3. 3) Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev., 46, 27–43 (2001).

4. 4) Zietek T, Boomgaarden WAD, Rath E. Drug screening, oral bioavailability and regulatory aspects: a need for human organoids. Pharmaceutics, 13, 1280 (2021).

5. 5) Calcagno AM, Ludwig JA, Fostel JM, Gottesman MM, Ambudkar SV. Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery. Mol. Pharm., 3, 87–93 (2006).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perfluoropolyether-Based Gut-Liver-on-a-Chip for the Evaluation of First-Pass Metabolism and Oral Bioavailability of Drugs;ACS Biomaterials Science & Engineering;2024-06-01

2. A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia;Pharmaceuticals;2024-02-19

3. Microfluidic Gut-on-A-Chip Systems for Drug Development: Recent Advances and Future Prospects;2024

4. Organ-on-chip models for intestinal permeability studies;Concepts and Models for Drug Permeability Studies;2024

5. Challenges in Permeability Assessment for Oral Drug Product Development;Pharmaceutics;2023-09-28